GENOCEA BIOSCIENCES INC (GNCA) Stock News
NASDAQ:GNCA - Nasdaq - US3724274010 - Common Stock
GNCA Latest News, Press Relases and Analysis
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More
Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Welcome back and get ready because we're starting off the week with a breakdown of the biggest pre-market stock movers for Tuesday!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Good morning! We're starting off another day of trading with an overview of the biggest pre-market stock movers for Thursday!
HAPP Stock Soars 38% as Happiness Development Embraces EVs
Happiness Development (HAPP) stock is charging higher on Wednesday after the Chinese nutrition company announced plans to develop EVs.
Genocea Biosciences Is Shutting Down. What GNCA Stock Investors Should Know.
Genocea Biosciences (GNCA) stock is on the move Wednesday after the bioscience company revealed its shutting down and delisting shares.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Rise and shine, traders! We're starting off the day with a breakdown of the biggest pre-market stock movers for Wednesday!
Genocea Announces Wind Down of Operations and Delisting From NASDAQ
CAMBRIDGE, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're getting ready for another full day of trading with a breakdown of the biggest pre-market stock movers for Wednesday!